The past decade has witnessed major breakthroughs in cancer immunotherapy. This
development has been largely motivated by cancer cell evasion of immunological control …

Despite continuous therapeutic progress, cancer remains an often fatal disease. In the early
2010s, first evidence in rodent models suggested promising antitumor action of gas plasma …

Background Immunotherapy represents the future of clinical cancer treatment. The type of
cancer cell death determines the antitumor immune response and thereby contributes to the …

Ferroptosis is a newly defined form of regulated cell death (RCD) characterized by iron
overload, lipid reactive oxygen species (ROS) accumulation, and lipid peroxidation, which is …

Ferroptosis is a recently discovered form of regulated cell death that is morphologically,
genetically, and biochemically distinct from apoptosis and necroptosis, and its potential use …

Immunogenic cell death (ICD) is a rapidly growing research area representing one of the
emerging therapeutic strategies of cancer immunotherapy. ICD is an umbrella term covering …

The immunogenicity of dying cancer cells determines the efficacy of anti-cancer therapy.
Photodynamic therapy (PDT) can induce immunogenic cell death (ICD), which is …

Regulated cell death (RCD) has a fundamental role in development, pathology, and tissue
homeostasis. In order to understand the RCD mechanisms, it is essential to follow these …

Melanoma is a malignant tumor with aggressive behavior. Vemurafenib, a BRAF inhibitor, is
clinically used in melanoma, but resistance to melanoma cytotoxic therapies is associated …

Tumor metastasis involves cells migrating directionally in response to external chemical
signals. Reactive oxygen species (ROS) in the form of H2O2 has been demonstrated as a …